Clinician's Roundtable

Host: Frank Cortazar, MD There are several challenges associated with the management of glomerular diseases like IgA nephropathy and C3 glomerulopathy. But in order to overcome those challenges, we must first have a firm understanding of them. That’s why Dr. Frank Cortazar from the New York Nephrology Vasculitis and Glomerular Center is here to break down those common challenges so we can work to better manage IgA nephropathy and C3 glomerulopathy.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Gates B. Colbert, MD, FASN When managing a rare disease like IgA nephropathy (IgAN), it’s essential to keep each individual patient at the center of it all, and this type of approach starts at the diagnostic stage. Joining Dr. Charles Turck to share strategies for providing patient-centered care throughout every step of the journey is Dr. Gates Colbert, Assistant Clinical Professor at Texas A&M College of Medicine. var _ss = _ss || []; _ss.push(['_setDomain', 'https://koi-3S29M6OVIS.marketingautomation.services/net']); _ss.push(['_setAccount', 'KOI-1FZ71YMSRUCN8I']); _ss.push(['_trackPageView']); window._pa = window._pa || {}; // _pa.orderId = "myOrderId"; // OPTIONAL: attach unique conversion identifier to conversions // _pa.revenue = "19.99"; // OPTIONAL: attach dynamic purchase values to conversions // _pa.productId = "myProductId"; // OPTIONAL: Include product ID for use with dynamic ads (function() { var ss = document.createElement('scri

Host: Frank Cortazar, MD Have you ever heard or thought that IgA nephropathy (IgAN) is only a short-term disease? Or that it’s benign? These are just some of the many common misconceptions surrounding IgAN, which is why Dr. Frank Cortazar from the New York Nephrology Vasculitis and Glomerular Center is here to help debunk these and other prevalent myths.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Carl P. Walther, MD The alternative complement pathway and the lectin pathway are the two pathways that are important in IgA nephropathy (IgAN). So how does the dysregulation of these two pathways impact disease progression, and how might this knowledge help us optimize our approach to treating patients with IgAN? Joining Dr. Charles Turck to answer those and other key questions is nephrology specialist Dr. Carl Walther.

Host: Mario R. Nacinovich, Jr., MSc Guest: Sally L. Baxter, MD, MSc The All of Us Research Program discovered how socioeconomic factors such as lower income and education levels were associated with lower odds of seeing an eye doctor. Mario Nacinovich joins Dr. Sally Baxter, an Assistant Professor of Ophthalmology and Biomedical Informatics at the University of California-San Diego, to explore how socioeconomic factors could impact care for patients with glaucoma.

Host: John J. Russell, MD Guest: Stanton Miller, MD, MPH, FACS Patients who live in an environment impacted by gun violence may face lifelong challenges. But addressing gun violence from a public health standpoint may help clinicians manage the biological, behavioral, and social aspects of this disease. Dr. John Russell is joined by Dr. Stan Miller from the Jefferson Center for Injury Research & Prevention to discuss how clinicians can reframe their approach.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Andrew Clark, MD Emerging treatment options have helped patients with HIV live longer, but the aging population faces its own unique challenges. To explore how we can combat these challenges—including the ongoing stigma around HIV—Dr. Charles Turck is joined by Dr. Andrew Clark, who is the Global Medical Lead at ViiV Healthcare.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: W. Frank Peacock, MD For patients with opioid-induced constipation (OIC), can Narcan play a role in finding a new treatment option? Dr. Charles Turck is joined by Dr. Frank Peacock from the Baylor College of Medicine to explore key data on the role of methylnaltrexone in the treatment of OIC.

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Wendy Wright, DNP, FNP-BC, ANP-BC, FAANP, FAAN, FNAP Physicians and advanced practice registered nurses (APRNs) may practice differently but they can still get their patient to the same outcome. So where do the conflicts arise? Join Dr. Peter Buch as he walks us through this with Dr. Wendy Wright, nurse practitioner and founder of Wright & Associates Family Healthcare.

Host: Mario R. Nacinovich, Jr., MSc Guest: Walter Koroshetz, MD Amyotrophic lateral sclerosis (ALS) is a rare neurogenerative disease, and organizations including the FDA and NIH are working to accelerate potential therapies. What’s on the horizon for the treatment landscape? Mario Nacinovich joins Dr. Walter Koroshetz, who is the Director of the National Institute of Neurological Disorders and Stroke, to explore these new developments.

Host: Mario R. Nacinovich, Jr., MSc Guest: Richard Kojan, MD As the fight against Ebola continues, can a new biosecure emergency care unit (CUBE) and therapeutic guidelines from the World Health Organization (WHO) help combat this disease? Mario Nacinovich joins study Dr. Richard Kojan, President of the Alliance for International Medical Action, to discuss these new guidelines.

Host: Mario R. Nacinovich, Jr., MSc Guest: Charles P. Gerba, MD A recent case of polio emerging in New York City have clinicians questioning whether or not we need to be concerned about a spread. What do we need to know about this case—and our potential risk—of polio? Joining Mario Nacinovich to take a look at this case is microbiologist Dr. Charles Gerba, a Professor of Environmental Science at the University of Arizona.

Host: Mario R. Nacinovich, Jr., MSc Guest: Charles P. Gerba, MD With rates of monkeypox continuing to rise, what do we need to know about this disease? And how easily can it spread from one person to another? Tune in to hear from renowned microbiologist, Dr. Charles Gerba, a Professor of Environmental Science at the University of Arizona as he explores these topics with Mario Nacinovich.

Host: Javed Butler, MD, MBA, MPH Guest: Tariq Shafi, MD Although population-level differences between estimated glomerular filtration rate (eGFR) and measured glomerular filtration rate are well-known, the individual-level differences are not. So what clinical implication can this have for our patients? Learn about these fresh findings with Dr. Javed Butler and Dr. Tariq Shafi, the John D. Bower Director of the Division of Nephrology and Professor of Medicine at the University of Mississippi Medical Center. Together, they discuss a recent study from the Annals of Internal Medicine that explored this topic.

Host: Mario R. Nacinovich, Jr., MSc Guest: Julia Bilinska, MD Guest: Aatish Patel, MD Monkeypox continues to spread around the globe, and its clinical manifestations can differ from what we’ve seen. What are the newest symptoms of this disease? Learn more about these manifestations from Drs. Aatish Patel and Julia Bilinska from Guy's and St. Thomas' NHS Foundation Trust in London as they talk about their research with Host, Mario Nacinovich.

Host: John J. Russell, MD Guest: Randy Young, MD As Monkeypox continues to spread across non-endemic countries more and more, how can we detect it in our patients? And what’s being done to stop the spread? Guest and fellow ReachMD Host Dr. Randy Young, a Pulmonary Disease and Critical Care Medicine physician, joins Dr. John Russell to discuss what physicians should be looking out for, and how this virus has impacted public health.

Host: John J. Russell, MD Guest: Amesh Adalja, MD Monkeypox is not something we’re used to seeing in non-endemic countries like North America and Europe. Yet its spreading has some experts scratching their heads. Dr. Amesh Adalja, a Senior Scholar at the Johns Hopkins Center for Health Security at the Bloomberg School of Public Health, shares with Dr. John Russell what clinicians need to know about monkeypox amid the global outbreak in non-endemic countries.

Host: Hector O. Chapa, MD, FACOG Guest: Naomi Whittaker, MD The challenges that come with conception can be strenuous and emotionally draining. But with emerging tools and technology, there are many ways we can help our patients conceive naturally. Dr. Naomi Whittaker, an OB/GYN physician, joins Host Dr. Hector Chapa to share these strategies.

Host: Jennifer Caudle, DO Guest: Leonard A Valentino, MD Unfortunately, recognizing and diagnosing patients with bleeding disorders is only the first of many challenges. Once a diagnosis is reached, patients may face a variety of chronic health challenges and even altered family dynamics. Fortunately, recent treatments and developments—and even those on the horizon—can help alleviate the burden of bleeding disorders on patients and their loved ones. Join Dr. Jennifer Caudle as she uncovers those important efforts with Dr. Leonard Valentino, President and Chief Executive Officer at the National Hemophilia Foundation.

Host: Hector O. Chapa, MD, FACOG Guest: Kellie Moore, ND We've all heard the phrase "you are what you eat." But are we now at a point where science is backing up that old saying? To find out how our diet can impact our cognitive function and mood, Dr. Hector Chapa speaks with naturopathic physician Dr. Kellie Moore. Together, they’ll review the foods that we should eat versus avoid and the resources we can use to help our patients have a healthy mind and body.